MedTech Actuator Global Navigator Program (Japan)

Deadline: 1-Sep-22

In partnership with JETRO, MedTech Actuator Global Navigator Japan offers growth-stage founders and entrepreneurs the opportunity to explore the Asia-Pacific market for the commercialisation of health innovation.

MedTech Actuator Global Navigator Japan program facilitates a smooth and accelerated pathway for growing ventures to access critical stakeholders, and market knowledge in the Asia-Pacific ecosystems as they expand their international efforts and capture new market opportunities.

Program experience

• Learn: From industry experts, founders, and MedTech Actuator
• Expand: Your startup into the Australian and Singaporean market efficiently
• Pitch: Your startup to keystone healthcare investors
• Network: with clinical experts and commercial stakeholders in the MedTech, BioTech and HealthTech startup ecosystem in Singapore and Australia

Eligibility Criteria

• Applicants to the Global Navigator program must:
  • Be a growth stage (Series A/B) MedTech, BioTech or HealthTech startup
  • Be highly motivated to expand into the Singapore and Australian ecosystem
  • Be able to attend all program activities in Singapore and Australia scheduled on the key dates
  • Have at least one team member living in OR based in Japan

Criteria

• Must be a Japanese start-up company (including SMEs) that is located in Japan and has global business in mind.
• In principle, have technology, products, and services (including prototypes) for overseas expansion.
• Ability to communicate in English when participating in the program (reference: English proficiency for technical explanations and business negotiations).
• Agree to the Terms of Use/Disclaimer/Confidentiality/Handling of Personal Information, and Cancellation Policy/Notes.
• Be able to participate in both Phase 1 and Phase 2 (participate in all dates in Phase 1). Phase 2 is Singapore or
• Participation in either Australia is allowed, but participation in the program of participating countries is mandatory. In addition, companies that can participate in both countries and all schedules preferentially adopt work.
• Persons who have authority over the decision-making of the company, such as executives such as managers and those responsible for overseas expansion, must be able to participate and travel locally.
• Satisfy the requirements for overseas travel, such as vaccinations.
• As of July 20, 2022, Singapore has vaccination requirements, and Australia has vaccination requirements due to the relaxation of requirements.
• Respond to the questionnaire conducted by the organizer to understand the business results, and be able to cooperate in disseminating the business results (seminars, etc.).

For more information, visit https://medtechactuator.com/japan-2022/